These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2286782)
1. Herpes zoster in patients with polymyositis and dermatomyositis. Nagaoka S; Tani K; Ishigatsubo Y; Chiba J; Kato K; Matsunaga K; Narita M; Igarashi T; Okubo T Kansenshogaku Zasshi; 1990 Nov; 64(11):1394-9. PubMed ID: 2286782 [TBL] [Abstract][Full Text] [Related]
2. [Clinical study on dermatomyositis-polymyositis complicated with herpes zoster]. Nagaoka S; Ishigatsubo Y; Chiba J; Kato K; Narita M; Sakamoto H; Tani K; Ito A; Okubo T Kansenshogaku Zasshi; 1984 Oct; 58(10):1033-7. PubMed ID: 6442317 [No Abstract] [Full Text] [Related]
3. Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis. Cunha GF; Souza FH; Levy-Neto M; Shinjo SK Clinics (Sao Paulo); 2013 May; 68(5):621-7. PubMed ID: 23778404 [TBL] [Abstract][Full Text] [Related]
4. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis. Leu CC; Lan JL Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148 [TBL] [Abstract][Full Text] [Related]
5. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746 [TBL] [Abstract][Full Text] [Related]
6. Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study. Tsai SY; Lin CL; Wong YC; Yang TY; Kuo CF; Cheng JM; Wang JS; Kao CH Medicine (Baltimore); 2015 Jul; 94(28):e1138. PubMed ID: 26181551 [TBL] [Abstract][Full Text] [Related]
7. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Oddis CV; Medsger TA; Cooperstein LA Arthritis Rheum; 1990 Nov; 33(11):1640-5. PubMed ID: 2242062 [TBL] [Abstract][Full Text] [Related]
8. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes]. Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267 [TBL] [Abstract][Full Text] [Related]
9. Clinical and serologic features of patients with polymyositis or dermatomyositis. Holden DJ; Brownell AK; Fritzler MJ Can Med Assoc J; 1985 Mar; 132(6):649-53. PubMed ID: 3872156 [TBL] [Abstract][Full Text] [Related]
10. [The principle antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. Study of 42 cases]. Meyer O; Cremer-Legmann F; Haim T; Ryckewaert A Presse Med; 1987 Feb; 16(4):155-8. PubMed ID: 2950445 [TBL] [Abstract][Full Text] [Related]
15. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751 [TBL] [Abstract][Full Text] [Related]
16. Myalgia in Patients with Dermatomyositis and Polymyositis Is Attributable to Fasciitis Rather Than Myositis: A Retrospective Study of 32 Patients who Underwent Histopathological Examinations. Noda K; Yoshida K; Ukichi T; Furuya K; Hirai K; Kingetsu I; Kurosaka D J Rheumatol; 2017 Apr; 44(4):482-487. PubMed ID: 28148694 [TBL] [Abstract][Full Text] [Related]